: Amid criticism for its handling of another Alzheimer’s drug, FDA will decide this week whether to approve lecanemab
A damning new congressional report found the regulator didn’t follow the correct procedures when it approved Aduhelm in 2021
TaxWatch: Brace yourself: Your tax refund could shrink in 2023. Here’s why.
A constantly changing tax code makes it hard for families to plan their financial lives, one expert says.
The Ratings Game: China is now a ‘reopening’ story for Starbucks, analysts say. Here’s what to watch for next.
As China emerges from almost three years of pandemic lockdowns, the coffee chain's rebound could run up against an array of complications, BofA analysts said.
: Kevin McCarthy House speaker vote: Here are the 19 Republicans who defected
19 Republicans voted against Kevin McCarthy on the first ballot in the House speaker election. Here's who they are
Financial Crime: Sam Bankman-Fried pleads not guilty in multi-billion dollar FTX fraud case
The FTX founder has been under house arrest since being charged with allegedly looting billions in customer deposits.
Deep Dive: 20 stocks expected by Goldman Sachs to gain the most from Washington’s clean-energy spending
The landmark legislation includes $391 billion in spending, which is expected to help earnings.
: Not every tech company is shaving jobs: These startups are on hiring binges
Some startups, especially those in AI, are flush with cash, providing a strong contrast to large employers that are shedding workers by the thousands.
: Cars and videogames: Nvidia rolls out $799 gaming card, partners with Foxconn on EVs
Nvidia Corp. shares dragged on the broader chip sector on the first day of 2023 trading Tuesday
Market Extra: Tesla stock wipes out three day bounce, hits lowest price in more than 2 years
Tesla stock falls to fresh lows after disappointing deliveries data, to knock the EV maker down to 15th on list of most valuable S&P 500...